- Active not recruitingPHASE3
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS)
This study is looking at a new medicine called Olezarsen for people with a rare condition called Familial Chylomicronemia Syndrome (FCS). It's a continuation of an earlier study, aiming to see more about how safe and effective Olezarsen is over a longer time.
For: Familial Chylomicronemia SyndromeUnited States · Canada · France - Active not recruitingPHASE3
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
This study is looking at a new medicine called Olezarsen for people with very high triglyceride levels. It's an ongoing study for those who have already started the treatment in previous trials, checking its long-term safety and how well it's tolerated.
For: Severe HypertriglyceridemiaUnited States · Argentina · Australia